{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:27:24Z","timestamp":1792801644905,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":2635,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Bioenergetics"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.bbabio.2006.05.001","type":"journal-article","created":{"date-parts":[[2006,5,12]],"date-time":"2006-05-12T15:16:04Z","timestamp":1147446964000},"page":"700-707","source":"Crossref","is-referenced-by-count":75,"title":["Anti-HIV drugs and the mitochondria"],"prefix":"10.1016","volume":"1757","author":[{"given":"Marcello","family":"Pinti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Salomoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cossarizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbabio.2006.05.001_bib1","unstructured":"http:\/\/www.unaids.org\/en\/HIV_data\/default.asp (2005)."},{"key":"10.1016\/j.bbabio.2006.05.001_bib2","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1073\/pnas.82.20.7096","article-title":"3\u2032-Azido-3\u2032-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III\/lymphadenopathy-associated virus in vitro","volume":"82","author":"Mitsuya","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbabio.2006.05.001_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/373123a0","article-title":"Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection","volume":"373","author":"Ho","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2006.05.001_bib4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/3293","article-title":"Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry","volume":"4","author":"Kilby","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbabio.2006.05.001_bib5","doi-asserted-by":"crossref","first-page":"F37","DOI":"10.1097\/00002030-199806000-00001","article-title":"Indinavir-associated lipodystrophy","volume":"12","author":"Viraben","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.bbabio.2006.05.001_bib6","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.bbabio.2006.05.001_bib7","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bbabio.2006.05.001_bib8","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/00002030-199911120-00019","article-title":"Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy","volume":"13","author":"Kakuda","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.bbabio.2006.05.001_bib9","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/bies.1152","article-title":"Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?","volume":"23","author":"Cossarizza","year":"2001","journal-title":"BioEssays"},{"key":"10.1016\/j.bbabio.2006.05.001_bib10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0006-2952(89)90245-1","article-title":"Studies on the inhibition of mitochondrial DNA replication by 3\u2032-azido-3\u2032-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication","volume":"38","author":"Simpson","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib11","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1016\/S0021-9258(18)80156-9","article-title":"Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2\u2032,3\u2032-dideoxycytidine","volume":"264","author":"Chen","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2006.05.001_bib12","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","article-title":"Mitochondrial myopathy caused by long-term zidovudine therapy","volume":"322","author":"Dalakas","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbabio.2006.05.001_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0140-6736(91)91294-5","article-title":"Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy","volume":"337","author":"Arnaudo","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.bbabio.2006.05.001_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.42.3.619","article-title":"31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV-infected patients","volume":"42","author":"Weissman","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.bbabio.2006.05.001_bib15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/AAC.44.3.496-503.2000","article-title":"Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells","volume":"44","author":"Pan-Zhou","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbabio.2006.05.001_bib16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.46.3.716-723.2002","article-title":"Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors","volume":"46","author":"Birkus","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbabio.2006.05.001_bib17","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1097\/00002030-200109070-00012","article-title":"Direct analysis of mitochondrial toxicity of antiretroviral drugs","volume":"15","author":"Foli","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.bbabio.2006.05.001_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/338564","article-title":"Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy","volume":"185","author":"Cossarizza","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbabio.2006.05.001_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00002030-200203080-00001","article-title":"Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy","volume":"16","author":"McComsey","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.bbabio.2006.05.001_bib20","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/00002030-200211080-00009","article-title":"Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors","volume":"16","author":"Walker","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.bbabio.2006.05.001_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00042560-200202010-00002","article-title":"Evidence of nucleoside analogue reverse transcriptase inhibitor-associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients","volume":"29","author":"Walker","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.bbabio.2006.05.001_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/135965350300800410","article-title":"Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy","volume":"8","author":"Miro","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbabio.2006.05.001_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/135965350400900109","article-title":"Mitochondrial effects of antiretroviral therapies in asymptomatic patients","volume":"9","author":"Lopez","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbabio.2006.05.001_bib24","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients","volume":"346","author":"Cote","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbabio.2006.05.001_bib25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrd1201","article-title":"Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective","volume":"2","author":"Lewis","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbabio.2006.05.001_bib26","first-page":"625","article-title":"Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity","volume":"39","author":"Chen","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib27","first-page":"228","article-title":"Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts","volume":"65","author":"Lewis","year":"1991","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbabio.2006.05.001_bib28","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1172\/JCI115722","article-title":"Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria","volume":"89","author":"Lewis","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbabio.2006.05.001_bib29","first-page":"742","article-title":"Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model","volume":"65","author":"Lamperth","year":"1991","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbabio.2006.05.001_bib30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0006-291X(91)91884-F","article-title":"The 5\u2032-triphosphates of 3\u2032-azido-3\u2032-deoxythymidine and 2\u2032, 3\u2032-dideoxynucleosides inhibit DNA polymerase gamma by different mechanisms","volume":"179","author":"Izuta","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbabio.2006.05.001_bib31","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/01.RES.74.2.344","article-title":"Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and noncompetitively by phosphorylated zidovudine","volume":"74","author":"Lewis","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbabio.2006.05.001_bib32","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.38.12.2743","article-title":"Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis","volume":"38","author":"Martin","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbabio.2006.05.001_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/labinvest.3780022","article-title":"Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine","volume":"80","author":"Lewis","year":"2000","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbabio.2006.05.001_bib34","doi-asserted-by":"crossref","first-page":"14620","DOI":"10.1021\/bi00252a030","article-title":"Mammalian DNA polymerases alpha, beta, gamma, delta, and epsilon incorporate fialuridine (FIAU) monophosphate into DNA and are inhibited competitively by FIAU Triphosphate","volume":"33","author":"Lewis","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbabio.2006.05.001_bib35","doi-asserted-by":"crossref","first-page":"18929","DOI":"10.1074\/jbc.270.32.18929","article-title":"Efficient incorporation of anti-HIV deoxynucleotides by recombinant yeast mitochondrial DNA polymerase","volume":"270","author":"Eriksson","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2006.05.001_bib36","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/0006-2952(94)90600-9","article-title":"Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases beta and gamma","volume":"48","author":"Cherrington","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0344-0338(96)80218-4","article-title":"Hepatic Morphological alterations induced by zidovudine (ZDV) in an experimental model","volume":"192","author":"Corcuera","year":"1996","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbabio.2006.05.001_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-510X(97)05376-8","article-title":"Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells","volume":"149","author":"Benbrik","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbabio.2006.05.001_bib39","first-page":"160","article-title":"2\u2032,3\u2032-Didehydro-3\u2032-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5\u2032-triphosphate biosynthesis","volume":"50","author":"Ahluwalia","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib40","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/0006-2952(92)90194-N","article-title":"The Friend murine erythroleukemia cell, a model system for studying the association between bone marrow toxicity induced by 3\u2032-azido-3\u2032-dideoxythymidine and dideoxynucleoside inhibition of mtDNA replication","volume":"43","author":"Hobbs","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0006-2952(95)00141-L","article-title":"Cellular targets of 3\u2032-azido-3\u2032-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation","volume":"50","author":"Hobbs","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/dna.1996.15.363","article-title":"AZT incorporation into mitochondria: study in a human myeloid cell line","volume":"15","author":"Nusbaum","year":"1996","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s004010050501","article-title":"Nuclear and mitochondrial changes of co-cultivated spinal cord, spinal ganglia and muscle fibers following treatment with various doses of zidovudine","volume":"92","author":"Schroder","year":"1996","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.bbabio.2006.05.001_bib44","first-page":"773","article-title":"The effect of L-carnitine on the AZT-induced destruction of human myotubes. Part II: treatment with L-carnitine improves the AZT-induced changes and prevents further destruction","volume":"71","author":"Semino-Mora","year":"1994","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbabio.2006.05.001_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0925-4439(96)00015-4","article-title":"Zidovudine and dideoxynucleosides deplete wild-type mitochondrial DNA levels and increase deleted mitochondrial DNA levels in cultured Kearns\u2013Sayre syndrome fibroblasts","volume":"1316","author":"Wang","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbabio.2006.05.001_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2004.03.005","article-title":"Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine","volume":"199","author":"Velsor","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.bbabio.2006.05.001_bib47","doi-asserted-by":"crossref","first-page":"M13","DOI":"10.1177\/135965350501002S03","article-title":"Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy","volume":"10","author":"Lewis","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbabio.2006.05.001_bib48","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0006-2952(96)00831-3","article-title":"3\u2032-Azido-3\u2032-deoxythmidine uptake into isolated rat liver mitochondria and impairment of ADP\/ATP translocator","volume":"53","author":"Barile","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0306-3623(98)00041-X","article-title":"Mitochondria as cell targets of AZT (zidovudine)","volume":"31","author":"Barile","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib50","doi-asserted-by":"crossref","first-page":"14355","DOI":"10.1016\/S0021-9258(17)36627-9","article-title":"3\u2032-Azido-3\u2032-deoxythymidine potently inhibits protein glycosylation. A novel mechanism for AZT cytotoxicity","volume":"269","author":"Hall","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2006.05.001_bib51","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1006\/bbrc.2001.5716","article-title":"Bystander effects of nucleoside analogs phosphorylated in the cytosol or mitochondria","volume":"287","author":"Sanda","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbabio.2006.05.001_bib52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1099-0844(199809)16:3<173::AID-CBF783>3.0.CO;2-4","article-title":"Mitochondrial sensitivity to AZT","volume":"16","author":"Pereira","year":"1998","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bbabio.2006.05.001_bib53","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1046\/j.1432-1033.2002.02954.x","article-title":"Azidothymidine causes functional and structural destruction of mitochondria, glutathione deficiency and HIV-1 promoter sensitization","volume":"269","author":"Yamaguchi","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbabio.2006.05.001_bib54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","article-title":"Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial","volume":"288","author":"Carr","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.bbabio.2006.05.001_bib55","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/01.aids.0000186019.47297.0d","article-title":"Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study","volume":"19","author":"Mussini","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.bbabio.2006.05.001_bib56","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbabio.2006.05.001_bib57","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.4049\/jimmunol.170.12.6006","article-title":"Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors","volume":"170","author":"Matarrese","year":"2003","journal-title":"J. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.bbabio.2006.05.001_bib58","doi-asserted-by":"crossref","first-page":"M29","DOI":"10.1177\/135965350501002S04","article-title":"HIV protease inhibitors prevent mitochondrial hyperpolarization and redox imbalance and decrease endogenous uncoupler protein-2 expression in gp 120-activated human T lymphocytes","volume":"10","author":"Matarrese","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbabio.2006.05.001_bib59","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1083\/jcb.126.6.1353","article-title":"Localization of HIV RNA in mitochondria of infected cells: potential role in cytopathogenicity","volume":"126","author":"Somasundaran","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib60","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00315010","article-title":"Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy","volume":"90","author":"Morgello","year":"1995","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.bbabio.2006.05.001_bib61","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00002030-200109280-00009","article-title":"Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy","volume":"15","author":"Shikuma","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.bbabio.2006.05.001_bib62","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/423176","article-title":"Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals","volume":"39","author":"Mir\u00f2","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbabio.2006.05.001_bib63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1468-1293.2005.00336.x","article-title":"Depletion of mitochondrial DNA copies\/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naive patients","volume":"7","author":"Maagaard","year":"2006","journal-title":"HIV Med."},{"key":"10.1016\/j.bbabio.2006.05.001_bib64","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1086\/497140","article-title":"Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy","volume":"192","author":"Casula","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbabio.2006.05.001_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0922-4106(92)90063-2","article-title":"gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine","volume":"226","author":"Muller","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib66","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/aid.1993.9.761","article-title":"Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells","volume":"9","author":"Laurent-Crawford","year":"1993","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.bbabio.2006.05.001_bib67","doi-asserted-by":"crossref","first-page":"H1672","DOI":"10.1152\/ajpheart.00955.2001","article-title":"Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage","volume":"282","author":"Raidel","year":"2002","journal-title":"Am. J. Physiol, Heart Circ. Physiol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.191.1.33","article-title":"The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore","volume":"191","author":"Jacotot","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbabio.2006.05.001_bib69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/s1016-8478(23)12897-4","article-title":"Role of HIV Vpr as a regulator of apoptosis and an effector on bystander cells","volume":"21","author":"Moon","year":"2006","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bbabio.2006.05.001_bib70","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/sj.cdd.4401089","article-title":"The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway","volume":"9","author":"Roumier","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbabio.2006.05.001_bib71","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/sj.cdd.4401094","article-title":"HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation","volume":"9","author":"Nie","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbabio.2006.05.001_bib72","first-page":"491","article-title":"Immunologic abnormalities in the acquired immunodeficiency syndrome (AIDS)","volume":"32","author":"Fauci","year":"1984","journal-title":"Clin. Res."},{"key":"10.1016\/j.bbabio.2006.05.001_bib73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/07357908509040606","article-title":"Human interleukin 2: biochemistry, physiology, and possible pathogenetic role in immunodeficiency syndromes","volume":"3","author":"Welte","year":"1985","journal-title":"Cancer Invest."},{"key":"10.1016\/j.bbabio.2006.05.001_bib74","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1096\/fasebj.5.10.2065887","article-title":"HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease","volume":"5","author":"Merrill","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.bbabio.2006.05.001_bib75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-065X.1992.tb01407.x","article-title":"IL-6 and NF-IL6 in acute-phase response and viral infection","volume":"127","author":"Akira","year":"1992","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbabio.2006.05.001_bib76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-5793(89)80454-5","article-title":"Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor","volume":"248","author":"Lancaster","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbabio.2006.05.001_bib77","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-291X(90)91242-K","article-title":"Induction of resistance to TNF cytotoxicity and mitochondrial superoxide dismutase on U-937 cells by 1,25-dihydroxyvitamin D3","volume":"170","author":"Iwamoto","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbabio.2006.05.001_bib78","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1016\/S0021-9258(18)42768-8","article-title":"Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation","volume":"267","author":"Schulze-Osthoff","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2006.05.001_bib79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4049\/jimmunol.141.1.99","article-title":"Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients","volume":"141","author":"Wright","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib80","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.142.2.431","article-title":"Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone","volume":"142","author":"Clouse","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib81","first-page":"111","article-title":"The role of interferon and tumor necrosis factor in the pathogenesis of AIDS","volume":"5","author":"Lau","year":"1990","journal-title":"J. Exp. Pathol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib82","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/01.RES.71.5.1268","article-title":"Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells","volume":"71","author":"Geng","year":"1992","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbabio.2006.05.001_bib83","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1089\/107999000750053799","article-title":"Cytochrome c release, mitochondrial membrane depolarization, caspase-3 activation, and Bax-alpha cleavage during IFN-alpha-induced apoptosis in Daudi B lymphoma cells","volume":"20","author":"Yanase","year":"2000","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bbabio.2006.05.001_bib84","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/172.1.105","article-title":"Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome","volume":"172","author":"Cossarizza","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbabio.2006.05.001_bib85","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s100960050388","article-title":"Reduction of immune system activation in HIV-1-infected patients undergoing highly active antiretroviral therapy","volume":"18","author":"Franco","year":"1999","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bbabio.2006.05.001_bib86","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0002-9343(88)90576-1","article-title":"Elevated levels of circulating cachectin\/tumor necrosis factor in patients with acquired immunodeficiency syndrome","volume":"85","author":"Lahdevirta","year":"1988","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbabio.2006.05.001_bib87","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ana.410360511","article-title":"Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers","volume":"36","author":"Gherardi","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib88","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0168-8278(99)80020-8","article-title":"Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion","volume":"30","author":"Chariot","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/019131299281798","article-title":"Comparative ultrastructural studies on mitochondrial pathology in the liver of AIDS patients: clusters of mitochondria, protuberances, \u201cminimitochondria,\u201d vacuoles, and virus-like particles","volume":"23","author":"Radovanovic","year":"1999","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib90","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00002030-200105250-00017","article-title":"Sperm mitochondrial DNA deletions as a consequence of long term highly active antiretroviral therapy","volume":"15","author":"White","year":"2001","journal-title":"AIDS"},{"issue":"Suppl. 2","key":"10.1016\/j.bbabio.2006.05.001_bib91","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1086\/313854","article-title":"HIV protease inhibitor-related lipodystrophy syndrome","volume":"30","author":"Carr","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbabio.2006.05.001_bib92","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/135965350100600102","article-title":"Antiretroviral therapy and the lipodystrophy syndrome","volume":"6","author":"John","year":"2001","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbabio.2006.05.001_bib93","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0140-6736(05)64011-1","article-title":"Benign symmetric lipomatosis associated with protease inhibitors","volume":"350","author":"Hengel","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bbabio.2006.05.001_bib94","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJM199903253401218","article-title":"Fat distribution in AIDS","volume":"340","author":"Teplitsky","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbabio.2006.05.001_bib95","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/00002030-200109070-00006","article-title":"Mitochondrial involvement in antiretroviral therapy-related lipodystrophy","volume":"15","author":"Zaera","year":"2001","journal-title":"AIDS"},{"issue":"Suppl. 2","key":"10.1016\/j.bbabio.2006.05.001_bib96","doi-asserted-by":"crossref","first-page":"M91","DOI":"10.1177\/135965350501002S10","article-title":"Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy","volume":"10","author":"Galluzzi","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbabio.2006.05.001_bib97","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00001432-200302000-00002","article-title":"Tests for mitochondrial function and DNA: potentials and pitfalls","volume":"16","author":"Cossarizza","year":"2003","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.bbabio.2006.05.001_bib98","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/00002030-199911120-00008","article-title":"Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy","volume":"13","author":"Domingo","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.bbabio.2006.05.001_bib99","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-002-0667-0","article-title":"Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy","volume":"441","author":"Lloreta","year":"2002","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbabio.2006.05.001_bib100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/135965350400900412","article-title":"Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients","volume":"9","author":"Jan","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbabio.2006.05.001_bib101","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2337\/diab.47.8.1365","article-title":"Human preadipocytes display a depot-specific susceptibility to apoptosis","volume":"47","author":"Niesler","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.bbabio.2006.05.001_bib102","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00002030-200401230-00002","article-title":"Antiretroviral nucleoside and nucleotide analogues and mitochondria","volume":"18","author":"Cossarizza","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.bbabio.2006.05.001_bib103","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1016\/S0021-9258(17)44633-3","article-title":"Mitochondrial DNA in mortal and immortal human cells. Genome number, integrity, and methylation","volume":"258","author":"Shmookler Reis","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2006.05.001_bib104","first-page":"1063","article-title":"Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content","volume":"46","author":"Zhang","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/135965350501000112","article-title":"Changes in mitochondrial RNA production in cells treated with nucleoside analogues","volume":"10","author":"Galluzzi","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbabio.2006.05.001_bib106","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1086\/429697","article-title":"In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA","volume":"191","author":"Mallon","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbabio.2006.05.001_bib107","first-page":"L15","article-title":"Role of platelet contamination in assessing mtDNA content in peripheral blood mononuclear cells","volume":"13","author":"Pinti","year":"2002","journal-title":"Antiviral. Ther."},{"key":"10.1016\/j.bbabio.2006.05.001_bib108","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jama.280.18.1569","article-title":"Trends in alternative medicine use in the United States, 1990\u20131997: results of a follow-up national survey","volume":"280","author":"Eisenberg","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.bbabio.2006.05.001_bib109","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/acm.2000.6.415","article-title":"Use of complementary medicine by adult patients participating in HIV\/AIDS clinical trials","volume":"6","author":"Sparber","year":"2000","journal-title":"J. Altern. Complement. Med."},{"key":"10.1016\/j.bbabio.2006.05.001_bib110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.0306-5251.2001.01516.x","article-title":"St. Johns wort increases expression of P-glycoprotein: implications for drug interactions","volume":"53","author":"Hennessy","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbabio.2006.05.001_bib111","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00126334-200309010-00004","article-title":"Factors associated with mitochondrial dysfunction in circulating peripheral blood lymphocytes from HIV-infected people","volume":"34","author":"Polo","year":"2003","journal-title":"J. Acquir. Immune Defic. Syndr."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Bioenergetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005272806001241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005272806001241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T11:09:43Z","timestamp":1707044983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005272806001241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":111,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0005272806001241"],"URL":"https:\/\/doi.org\/10.1016\/j.bbabio.2006.05.001","relation":{},"ISSN":["0005-2728"],"issn-type":[{"value":"0005-2728","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}